1International League Against Epilepsy (ILAE). ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes[J]. Epilepsia, 2006, 47 : 1094.
2SANAD Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial[J]. Lancet, 2007, 369: 1000.
3Kwan P, Brodie MJ. Early identification of refractory epilepsy[ J]. N Engl J Med, 2000, 342: 314.
5Kim LG, Johnson TI,, Marson AG, et al. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further resuits from the MESS trlal[J]. Lancet Neurol, 2006, 5: 317.
6Ramos-Lizana J, Cassinello-Garcia E, Carrasco-Marina L, et al. Remission of epilepsy after onset of antiepileptic treatment: a prospective study in childhood[J].Rev Neurol, 2001, 33: 1021.
7Del Felice A, Beghi E, Boero G, et al. Early versus late remission in a cohort of patients with newly diagnosed epilepsy[ J]. Epilepsia, 2009, 50: 1.
8First Seizure Trial Group ( FIRST Group). Treatment of first tonicclonic seizure does not improve the prognosis of epilepsy[ J]. Neurology, 1997, 49:991.
9Berg AT, Shinnar S, Levy SR, et al. Two-year remission and subsequent relapse in children with newly diagnosed epilepsy[J]. Epilepsia, 2001,42: 1553.
10Elwes RD, Johnson AL, Shorvon SD, et al. The prognosis for seizure control in newly diagnosed epilepsy[J]. N Engl J Med, 1984, 311 : 944.
